Bachem Holding AG/€BANB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Bachem Holding AG
Bachem Holding AG is a Swiss-based company specializing in the development and manufacturing of peptides and oligonucleotides, primarily serving the pharmaceutical and biotechnology industries. With its expertise in this niche area, Bachem offers products including active pharmaceutical ingredients (APIs) and research chemicals. Founded in 1971, the company has positioned itself as a key supplier for both commercial and clinical-stage clients. Bachem has production sites in Switzerland, Germany, the United Kingdom, and the United States, allowing for a robust global presence. The company's strategic positioning benefits from its focus on high-quality, innovative manufacturing processes that comply with stringent regulatory standards.
Ticker
€BANB
Sector
Primary listing
XGAT
Employees
2,363
Headquarters
Bubendorf, Switzerland
Website
BANB Metrics
BasicAdvanced
€6.4bn
39.60
€2.17
0.78
€0.98
0.57%
Price and volume
Market cap
€6.4bn
Beta
0.78
52-week high
€91.25
52-week low
€51.69
Average daily volume
560
Dividend rate
€0.98
Financial strength
Current ratio
1.792
Quick ratio
0.541
Long term debt to equity
0.005
Total debt to equity
4.133
Dividend payout ratio (TTM)
20.65%
Interest coverage (TTM)
420.36%
Profitability
EBITDA (TTM)
230.736
Gross margin (TTM)
28.74%
Net profit margin (TTM)
21.41%
Operating margin (TTM)
24.07%
Effective tax rate (TTM)
4.86%
Revenue per employee (TTM)
€317,490
Management effectiveness
Return on assets (TTM)
5.19%
Return on equity (TTM)
10.44%
Valuation
Price to earnings (TTM)
39.598
Price to revenue (TTM)
8.477
Price to book
4.01
Price to tangible book (TTM)
4.09
Price to free cash flow (TTM)
-101.896
Free cash flow yield (TTM)
-0.98%
Free cash flow per share (TTM)
-0.844
Dividend yield (TTM)
1.14%
Forward dividend yield
0.57%
Growth
Revenue change (TTM)
14.84%
Earnings per share change (TTM)
23.77%
3-year revenue growth (CAGR)
9.34%
10-year revenue growth (CAGR)
12.79%
3-year earnings per share growth (CAGR)
13.28%
10-year earnings per share growth (CAGR)
15.50%
3-year dividend per share growth (CAGR)
6.27%
10-year dividend per share growth (CAGR)
7.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs